Cardiovascular adverse events in the drug‐development program of bupropion for smoking cessation: A systematic retrospective adjudication effort

BACKGROUND: In 2011, the US Food and Drug Administration requested that GlaxoSmithKline perform retrospective adjudication of cardiovascular (CV) events reported in the bupropion drug‐development trials for smoking cessation. HYPOTHESIS: Retrospective adjudication of clinical trial data will not inc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Kittle, Jessie, Lopes, Renato D., Huang, Mingyan, Marquess, Marsha L., Wilson, Matthew D., Ascher, John, Krishen, Alok, Hasselblad, Vic, Kolls, Brad J., Roe, Matthew T., McGuire, Darren K., Russell, Stuart D., Mahaffey, Kenneth W.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2017
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490529/
https://ncbi.nlm.nih.gov/pubmed/28605035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22744
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados